Dr. Peter Molan, my mentor, the late Dr. Peter Molan, former professor at the national University of Waikato and a leading researcher of active substances derived from  the Manuka tree, also published papers expressing concern about the issues mentioned above (as referenced in yesterday’s blog). Living in  New Zealand, I was fortunate to have opportunities to speak with him personally. The more I listened to Dr. Molan, the more astonished I  became at the remarkable active substances that exist naturally.

The beneficial components of Manuka exhibit exceptional activity. While our New Zealand office website primarily focuses  on the much-discussed Helicobacter pylori bacteria, its activity is not limited to this. Notably, Manuka’s active substances are  relevant against hospital-acquired infections, such as MRSA (Methicillin-Resistant Staphylococcus aureus), which emerged due to the  overuse of cephalosporin antibiotics, as well as VRE (Vancomycin-Resistant Enterococci) and VRSA (Vancomycin-Resistant Staphylococcus  aureus), both resistant even to vancomycin, considered the most potent antibiotic.

While a healthy body with a strong immune system can typically defend itself against these bacteria, individuals with weakened immune systems  can become extremely problematic due to the lack of effective treatments. It is essential to recognize that these drug-resistant  bacteria have emerged as a direct result of the misuse of antimicrobial agents.  Therefore, active substances with entirely different mechanisms of action bear no relation to this issue.